发明名称 Enzyme inhibitors
摘要 <p>Compounds of formula (I) are inhibitors of histone deacetylase activity, and are useful in the treatment of, for example, cancers, wherein Ris a carboxylic acid group (-COOH), or an ester group which is hydrolysable by one or more intracellular carboxyesterase enzymes to a carboxylic acid group; Ris the side chain of a natural or non-natural alpha amino acid; Y is a bond, -C(=O)-, -S(=O)-, -C(=O)O-, -C(O)NR-, -C(=S)-NR , -C(=NH)NR or -S(=O)NR- wherein R is hydrogen or optionally substituted C-C alkyl; L is a divalent radical of formula -(Alk)(Q)(Alk)- wherein m, n and p are independently 0 or 1 , Q is (i) an optionally substituted divalent mono- or bicyclic carbocyclic or heterocyclic radical having 5 - 13 ring members, or (ii), in the case where both m and p are 0, a divalent radical of formula -X-Q- or -Q-X- wherein X is -O-, S- or NR- wherein R is hydrogen or optionally substituted C-C alkyl, and Q is an optionally substituted divalent mono- or bicyclic carbocyclic or heterocyclic radical having 5 - 13 ring members, AIk and AIk independently represent optionally substituted divalent C-C cycloalkyl radicals, or optionally substituted straight or branched, C-C alkylene, C-C alkenylene ,or C-C alkynylene radicals which may optionally contain or terminate in an ether (-O-), thioether (-S-) or amino (-NR-) link wherein R is hydrogen or optionally substituted C-C alkyl; X represents a bond; -C(=O); or -S(=O)-; -NRC(=O)-, -C(=O)NR-, -NRC(=O)NR- , -NRS(=O)-, or -S(=O)NR-wherein R and R are independently hydrogen or optionally substituted C-C alkyl; z is 0 or 1 ; A represents an optionally substituted mono-, bi- or tri-cyclic carbocyclic or heterocyclic ring system wherein the radicals RRNH-Y-L-X-[CH]- and HONHCO-[LINKER]- are attached different ring atoms; and -[Linker]- represents a divalent linker radical linking a ring atom in A with the hydroxamic acid group CONHOH, the length of the linker radical, from the terminal atom linked to the ring atom of A to the terminal atom linked to the hydroxamic acid group, is equivalent to that of an unbranched saturated hydrocarbon chain of from 3-10 carbon atoms.</p>
申请公布号 AU2006243065(B2) 申请公布日期 2012.05.03
申请号 AU20060243065 申请日期 2006.05.04
申请人 CHROMA THERAPEUTICS LTD 发明人 DONALD, ALISTAIR DAVID GRAHAM;MAZZEI, FRANCESCA ANN;DRUMMOND, ALAN HASTINGS;BAKER, KENNETH WILLIAM JOHN;DAVIDSON, ALAN HORNSBY;DAVIES, STEPHEN JOHN;MOFFAT, DAVID FESTUS CHARLES;PATEL, SANJAY RATILAL
分类号 C07D487/04;A61K31/4045;A61K31/4353;A61K31/4965;A61P35/00;C07C259/06;C07C275/24;C07C311/46;C07D207/40;C07D207/416;C07D209/42;C07D213/40;C07D217/02;C07D217/12;C07D217/22;C07D295/18;C07D295/185;C07D333/62;C07D333/70;C07D471/04 主分类号 C07D487/04
代理机构 代理人
主权项
地址